| Name: | Aurobindo Pharma U.S.A., Inc. |
| Jurisdiction: | Alaska |
| Legal type: | Business Corporation |
| Status: | Good Standing |
| Date of registration: | 02 Mar 2020 (5 years ago) |
| Entity Number: | 10126305 |
| Place of Formation: | NEW JERSEY |
| Address: | 279, PRINCETON HIGHTSTOWN RD, CHIEF FINANCIAL OFFICER, NJ 08520 |
| Mailing Address: | 279 PRINCETON HIGHTSTOWN ROAD, EAST WINDSOR, NJ 08520 |
Line of Business
31-33 ManufacturingNAICS
325412 PHARMACEUTICAL PREPARATION MANUFACTURING| Name | Role |
|---|---|
| Swami Iyer | Director |
| Biren Shah | Treasurer |
| Aurobindo Pharma Ltd. | Shareholder |
| Corporation Service Company | Registered Agent |
| Type | License Number | Status | Date of issue | Date of renewal | Expiration date | Description |
|---|---|---|---|---|---|---|
| Business License | 2105619 | Active | 2020-05-18 | 2023-10-11 | 2025-12-31 | LOB: 31-33 - Manufacturing, NAICS: 325412 - PHARMACEUTICAL PREPARATION MANUFACTURING |
| Wholesale Drug Distributor | 161237 | Active | 2020-10-06 | - | 2026-06-30 | - |
| Third-Party Logistics Provider | 187244 | Active | 2021-12-22 | - | 2026-06-30 | - |
Date of last update: 10 Jan 2025
Sources: State of Alaska - Department of Commerce, Community, and Economic Development
